Bristol Myers Squibb (BMY) Other Non-Current Assets (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Other Non-Current Assets for 18 consecutive years, with $6.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 7.45% year-over-year to $6.4 billion in Q2 2026; TTM through Jun 2026 was $6.4 billion, a 7.45% increase from a year earlier, with the FY2025 full-year figure at $6.5 billion, up 6.04% from the prior year.
• Other Non-Current Assets was $6.4 billion for Q2 2026 at Bristol Myers Squibb, up from $6.1 billion in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $6.5 billion in Q4 2025 and troughed at $53.0 million in Q1 2023.
• A 5-year average of $4.0 billion and a median of $5.9 billion in 2025 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets slumped 97.06% in 2022 and surged 11354.72% in 2024, its largest moves.
• Over 5 years, Other Non-Current Assets stood at $4.9 billion in 2022, then gained by 8.7% to $5.4 billion in 2023, then increased by 13.69% to $6.1 billion in 2024, then gained by 6.04% to $6.5 billion in 2025, then slipped by 1.48% to $6.4 billion in 2026.
• The last three Other Non-Current Assets figures came in at $6.4 billion (Q2 2026), $6.1 billion (Q1 2026), and $6.5 billion (Q4 2025), per Business Quant data.